drugset
drugset / Trial / NCT02750384

Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects

NCT02750384 ↗

Phase 1 Terminated 11 enrolled Medicines for Malaria Venture AbbVie · collab
RandomizedParallel-groupOpen-label

Summary

This is a single-dose, fasting and non-fasting, open-label, randomized, three-regimen, parallel group study in 42 subjects

Timeline

Start
2016-05
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject DSM265 Small molecule 400 mg Oral

Indications

No indication recorded.